Gilead Sciences reported $19.71B in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acorda Therapeutics ACOR:US $ 190.48M 15.8M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
ALKERMES ALKS:US $ 1097.9M 46.75M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amgen AMGN:US $ 8247M 1087M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Biogen BIIB:US $ 10751.9M 69.7M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Bristol Myers Squibb BMY:US $ 36808M 797M
Coherus Biosciences CHRS:US $ 156.22M 28.55M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Glaxosmithkline GSK:US $ 15377M 512M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Moderna Inc MRNA:US 6.7B 2.87B
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NOVN:VX SF 54042M 3519M
Ptc Therapeutics PTCT:US $ 196.58M 96M
Puma Biotechnology PBYI:US $ 29.47M 13.03M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Teva Pharmaceutical Industries TEVA:US $ 10324M 324M
United Therapeutics UTHR:US $ 3639.5M 194.1M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M
YTE INCY:US $ 2935.86M 208.02M